Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I/II study to Evaluate JadiCell for the Treatment of Brain Injuries

X
Trial Profile

A phase I/II study to Evaluate JadiCell for the Treatment of Brain Injuries

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 24 Dec 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Allogeneic umbilical cord mesenchymal stem cells-Therapeutic Solutions International (Primary)
  • Indications Brain injuries; Traumatic brain injuries
  • Focus Adverse reactions
  • Sponsors Therapeutic Solutions International
  • Most Recent Events

    • 17 Dec 2020 According to a Therapeutic Solutions International media release, the company announced the filing of an Investigational New Drug (IND) application seeking permission from the Food and Drug Administration (FDA) to initiate this study.
    • 05 Oct 2020 New trial record
    • 28 Sep 2020 According to a Therapeutic Solutions International media release, the company is working to assemble the Investigational New Drug (IND) Application with the FDA to begin clinical trials on this terrible condition (brain injuries, including chronic traumatic encephalopathy).
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top